Rothschild Investment LLC increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 255.7% during the third quarter, Holdings Channel.com reports. The fund owned 11,696 shares of the company’s stock after buying an additional 8,408 shares during the period. Rothschild Investment LLC’s holdings in GE HealthCare Technologies were worth $765,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. NBH Bank bought a new stake in GE HealthCare Technologies in the second quarter valued at approximately $26,000. First Eagle Investment Management LLC raised its holdings in GE HealthCare Technologies by 77.6% during the 3rd quarter. First Eagle Investment Management LLC now owns 437 shares of the company’s stock worth $29,000 after purchasing an additional 191 shares during the last quarter. Provenance Wealth Advisors LLC raised its holdings in GE HealthCare Technologies by 401.0% during the 3rd quarter. Provenance Wealth Advisors LLC now owns 491 shares of the company’s stock worth $32,000 after purchasing an additional 393 shares during the last quarter. Fortitude Family Office LLC raised its holdings in GE HealthCare Technologies by 249.1% during the 3rd quarter. Fortitude Family Office LLC now owns 597 shares of the company’s stock worth $39,000 after purchasing an additional 426 shares during the last quarter. Finally, Aberdeen Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter worth approximately $44,000. 82.06% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have recently commented on GEHC. Piper Sandler reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th. Barclays increased their price objective on shares of GE HealthCare Technologies from $85.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, October 29th. Royal Bank Of Canada lifted their target price on shares of GE HealthCare Technologies from $80.00 to $90.00 and gave the stock an “outperform” rating in a research note on Thursday, October 29th. Citigroup lifted their target price on shares of GE HealthCare Technologies from $71.00 to $79.00 and gave the stock a “neutral” rating in a research note on Thursday, October 29th. Finally, Bank of America restated a “neutral” rating on shares of GE HealthCare Technologies in a report on Thursday, October 29th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $82.52.
View Our Latest Analysis on GE HealthCare Technologies
GE HealthCare Technologies Trading Down 1.6%
NASDAQ GEHC opened at $80.54 on Friday. The business has a 50 day simple moving average of $72.19 and a 200 day simple moving average of $70.19. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The stock has a market capitalization of $36.42 billion, a P/E ratio of 16.99, a P/E/G ratio of 2.09 and a beta of 0.65. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.30 and a quick ratio of 1.01.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The business had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. During the same period in the previous year, the company posted $1.07 earnings per share. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. Research analysts expect that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current year.
GE HealthCare Technologies Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Friday, October 23rd were given a dividend of $0.04 per share. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date of this dividend was Friday, October 23rd. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.38%.
About GE HealthCare Technologies
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
